Method of treating viral hepatitis by administration of liquid human -interferon


Use of natural human -interferon for the preparation of a medicament in liquid form to be administered through peroral route at dosages comprised between 100 UI and 500 UI/day, for therapy of viral infections, in particular viral hepatitis, neoplasia and immune diseases in humans and animals.


< Methods for modulating antigen-specific immune responses

< Substituted cycloalkyl P1' hepatitis C virus inhibitors

> Pyrazole ether derivatives as anti-inflammatory/analgesic agents

> Sustained release formulation containing tacrolimus

~ 00176